1. Home
  2. RAAQ vs NVCT Comparison

RAAQ vs NVCT Comparison

Compare RAAQ & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RAAQ

Real Asset Acquisition Corp. Class A Ordinary Share

HOLD

Current Price

$10.45

Market Cap

242.0M

Sector

N/A

ML Signal

HOLD

Logo Nuvectis Pharma Inc.

NVCT

Nuvectis Pharma Inc.

HOLD

Current Price

$7.48

Market Cap

220.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAAQ
NVCT
Founded
2024
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.0M
220.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RAAQ
NVCT
Price
$10.45
$7.48
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
129.0K
49.8K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.62
$5.55
52 Week High
$10.80
$11.52

Technical Indicators

Market Signals
Indicator
RAAQ
NVCT
Relative Strength Index (RSI) 43.95 29.63
Support Level $10.22 $7.23
Resistance Level $10.48 $8.46
Average True Range (ATR) 0.11 0.43
MACD -0.03 -0.16
Stochastic Oscillator 8.68 0.00

Price Performance

Historical Comparison
RAAQ
NVCT

About RAAQ Real Asset Acquisition Corp. Class A Ordinary Share

Real Asset Acquisition Corp is a blank check company.

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Share on Social Networks: